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To my Mother, Git and my late Father, Bosse, 
 
Both of whom have experienced cardiac arrest 
  
  
  
ABSTRACT 
Background 
Among Out-of-Hospital Cardiac Arrest (OHCA) patients, where resuscitation efforts have 
been initiated, only about 25% are admitted alive to hospital. To optimize the chance of 
survival it is of great importance to identify and treat the underlying cause of the cardiac 
arrest. The overall aim of the current work was to study different diagnostic approaches in 
OHCA patients and to evaluate if early coronary angiography, with potential subsequent 
percutaneous coronary intervention (PCI), could improve outcome. 
 
Methods and results 
 
Study I. A national observational retrospective study, evaluating the effect on survival of 
early coronary angiography vs. no early coronary angiography in witnessed, unconscious 
OHCA patients with shockable rhythm and without ST-elevation on the first ECG. 
Unadjusted 30-day survival in the early-angiography group was 65%, compared with 52% in 
the no-early-angiography group. The adjusted OR for 30-day survival was 1.42 for early 
angiography (95% CI 1.00-2.02, p=0.048). The adjusted HR for one-year survival was 1.35 
for early angiography (95% CI 1.04-1.77, p=0.03). 
Study II. An open-label, prospective, randomized, national multicenter clinical study in 
OHCA patients carried out to assess feasibility and safety aspects in a strategy of coronary 
angiography within 120 minutes from first medical contact versus coronary angiography 
potentially performed at a later stage. Among 79 randomized patients (from 2015 to 2017), 
39 were randomized to immediate coronary angiography and 40 to standard-of-care 
treatment. The median time from EMS arrival to coronary angiography was 135 minutes in 
the immediate-angiography group. A culprit lesion was found in 14/38 (36.8 %) patients 
randomized to immediate coronary angiography and PCI was performed in all these patients. 
In patients randomized to standard of care treatment 6/40 (15%) underwent coronary 
angiography before the stipulated three days.  
Study III. A retrospective, descriptive, single-center study, assessing the use of Focused 
Cardiac Ultrasound (FOCUS) in cardiac-arrest patients with ROSC and without ST-
elevations on the ECG. In total, FOCUS was performed in 237 (182 OHCA and 55 in-
hospital cardiac arrest) patients. FOCUS findings had an impact on management and led to 
further immediate diagnostic measures in 52 (21.9%) patients. 
Study IV. A sub-study of Study II carried out to compare post-resuscitation myocardial 
function in the two randomized groups. In the immediate angiography group, median left-
ventricle ejection fraction (LVEF) at 24 hours was 47% (Q1-Q3; 30-55) compared with 46% 
(Q1-Q3; 35-55) in the standard-of-care group. The peak Troponin-T level during the first 24 
hours was 362 ng/L (Q1-Q3; 174-2020) in the immediate-angiography group compared with 
377 ng/L (Q1-Q3;205-1078) in the standard-of-care group. 
Conclusions:  
In a Swedish OHCA population with shockable rhythm without ST-elevation, early coronary 
angiography may be associated with improved short- and long-term survival. 
Randomizing OHCA patients without ST-elevation to a strategy of immediate coronary 
angiography was feasible. No significant safety issues were observed.  
No differences in post-resuscitation myocardial dysfunction parameters between the two 
groups were found. 
Post-resuscitation assessment could include FOCUS as an adjunctive diagnostic measure 
shortly after ROSC. 
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1 RESEARCH QUESTION AND RATIONALE 
This thesis is focused mainly on adult out-of-hospital cardiac arrest (OHCA) patients who 
have achieved return of spontaneous circulation (ROSC) but remain comatose at hospital 
arrival. Approximately 25% of patients treated by the emergency medical services (EMS) are 
admitted alive to hospital1.  
 
Management of the post-cardiac arrest patients includes determining, and if possible, treating 
the cause of the arrest. Even though electrocardiogram (ECG) is an important tool to identify 
ST-elevations, indicating acute coronary occlusion, the vast majority of cardiac-arrest patients 
do not have ST-elevation2-5. Furthermore, these patients are most often unconscious and 
unable to share their medical history. Observational studies have revealed that approximately 
25 % have a coronary occlusion6. Thus, ECG has been shown to be insufficient in predicting 
an acute coronary event and currently there is a knowledge gap as to how clinicians should 
manage OHCA patients without ST-elevation. 
 
Although international guidelines suggest that coronary angiography should be considered in 
patients with resuscitated cardiac arrest without ST-elevation on ECG and with a high 
suspicion of ongoing myocardial infarction7-9, the existing scientific evidence in favor of 
routine use of coronary angiography after OHCA is insufficient. To find methods to improve 
the identification of those patients who would benefit from early coronary angiography would 
be of great value for patients and care givers. 
  
The overall aim of this work was to evaluate coronary angiography and other diagnostic 
approaches in out-of-hospital cardiac-arrest patients and to investigate if early coronary 
angiography and potential subsequent percutaneous coronary intervention (PCI) could 
improve outcome. 
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2 INTRODUCTION 
2.1 OUT-OF-HOSPITAL CARDIAC ARREST 
2.1.1 Definition 
Out-of-hospital cardiac arrest (OHCA) is defined as the “cessation of cardiac mechanical 
activity as confirmed by the absence of signs of circulation, occurring outside of a hospital 
setting”10. 
2.1.2 Incidence 
The total annual number of adult patients affected by OHCA, where resuscitation efforts have 
been initiated or continued by emergency medical services (EMS) has been estimated to be 
275,000 in Europe11 and 356,000 in the United States12,13. Substantial regional variations 
exist in reporting systems, data collection and reporting survival14-16.  
There is still a knowledge gap regarding the true incidence of OHCA. An effort to better 
understand this has been carried out by Berdowski et al., reporting the global incidence of 
adult EMS-treated OHCA to be 62.3 cases/100,000 person-years17. The incidence of OHCA 
when defined as the total number of OHCA events where resuscitation efforts have been 
initiated or continued by the EMS is 37.7- 49.0/100,000 person-years in Europe11,18 and 
47.3/100,000 person-years in North America17. The number of reported EMS-treated cases in 
Sweden has been estimated to 52/100,000 person-years19,20.   
2.1.3 Overall survival and prognostic factors 
The overall survival rate after resuscitation attempts by the EMS has been reported to be 
10%21. The most important predictors of survival from OHCA are: 
1. The presence of ventricular fibrillation (VF) or pulseless ventricular tachycardia 
(pVT) as the first recorded rhythm22, these being the strongest predictors of survival. 
Among patients found in VF/pVT and treated with a public automated external 
defibrillator (AED), survival can be as high as 70%23. On the other hand, for each 
shock delivered, the chance of survival decreases, and if more than 10 defibrillations 
are delivered the survival rate is 5%24 which underscores the fact that time to ROSC is 
crucial for survival. 
2. Witnessed cardiac arrest25, which is logical since witnessed OHCA is associated with 
bystander cardiopulmonary resuscitation (CPR)26,27 and a higher incidence of VF 
compared with unwitnessed OHCA28. 
3. Public location is associated with higher survival rates29 and is associated with 
witnessed OHCA and VF as first rhythm. However, most cases of OHCA occur at 
home. 
4. A relatively low age, this being associated with a higher survival rate30 ,although it is 
weaker compared with other predictors. 
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In patients with an initial shockable rhythm and comatose on admission to hospital after 
ROSC, 35-50% will survive 30 days with a reasonable neurological status31,32. Survival from 
the scene of arrest to hospital admission varies between regions and ranges from 22-57%, 
mostly because of regional culture, treatment differences and regional initiatives to optimize 
the effectiveness of the local chain of survival18,31,33-35. 
 
2.2 THE CHAIN OF SURVIVAL 
With the purpose of improving survival from OHCA, the American Heart Association 
(AHA) presented a statement in 199133 called “The chain of survival”. The concept initially 
concerned mainly pre-hospital factors. However, during the last two decades post-
resuscitation care has been more emphasized. The links in the chain of survival are: 
• Early recognition of symptoms and call for help.  
• Early CPR, bystander CPR most preferably. 
• Early defibrillation either by using a public AED or by EMS personnel. 
• Post-resuscitation care. For further treatment and prognostication. 
 
Figure 1. Nolan et al.36. Reprinted with permission from Elsevier. 
The chain of survival includes the community, emergency medical dispatch, EMS and 
receiving hospitals. The most important links in the chain of survival are the earliest ones, 
early recognition of cardiac arrest, initiation of CPR and early defibrillation34. For untrained 
witnesses or relatives, recognition of a cardiac arrest is not straightforward and in such a 
stressful moment call for help is difficult and requires calmness. Every minute that a patient 
with OHCA goes without CPR and defibrillation, the chance of survival decreases by 
approximately 10%35. The chain of survival is essential for patients to survive to hospital 
admission and, subsequently, to hospital discharge.  
Most patients who survive the initial resuscitation treatment are unconscious at hospital 
admittance, but some patients regain consciousness immediately after ROSC if early 
recognized as cardiac arrest and provided with treatment. The proportion of conscious 
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patients resuscitated from OHCA ranges from 15-36%, depending on the population 
studied37-40. Awake survivors of OHCA have limited or no brain injury and represent a less 
complicated group as regards post-resuscitation treatment and have a survival rate of 90-
96%38,41. 
2.3 ETIOLOGY OF OHCA 
Finding the etiology of cardiac arrest is important because it enables specific treatment of the 
underlying cause. Overall, the final etiology of the cardiac arrest differs between populations.   
 
Table 1. Overview of etiologies 
Ischemic heart 
disease 
Non-ischemic heart 
disease 
No structural heart 
disease 
Non-cardiac 
disease 
Acute coronary 
lesion 
Dilated cardiomyopathy Idiopathic ventricular 
fibrillation 
Lung disease, 
COPD, pneumonia 
Chronic 
coronary artery 
disease 
Hypertrophic 
cardiomyopathy 
Long QT syndrome, 
congenital or acquired 
Intracerebral 
bleeding 
Coronary 
artery 
dissection 
Valvular heart disease Brugada syndrome Pulmonary 
embolism 
Coronary 
artery spasm 
Myocarditis Catecholaminergic 
polymorphic ventricular 
tachycardia, CPVT 
Asphyxia, 
drowning 
Congenital 
coronary artery 
anomaly 
Acute pericardial 
tamponade 
Wolf-Parkinson White 
syndrome 
Seizures 
 Aortic dissection  Intoxication 
 Arrhythmogenic right 
ventricular 
cardiomyopathy, ARVC 
 Hypothermia 
 Acute myocardial 
rupture 
 Trauma, 
hypovolemia 
 Congenital heart disease  Electrolyte 
disturbances 
 Cardiac sarcoidosis  Septic shock 
 
In early autopsy studies, ischemic heart disease was found to be the major cause of cardiac 
arrest, responsible for 59-61% of all deaths42,43. This has been contradicted in one of the more 
recent autopsy studies, which revealed that only 32% of sudden cardiac deaths had stable or 
acute coronary heart disease as the etiology44.  
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In a French publication describing patients admitted alive to an intensive care unit (ICU), and 
using an extensive diagnostic strategy, the arrest was attributed to a non-cardiac cause 
(neurological, acute respiratory failure and intoxication) in 1/3 of the patients and a cardiac 
cause in 2/3 of the them45. Among the cardiac causes, acute coronary syndrome accounted for 
60% (37% if including non-cardiac causes) and chronic ischemic heart disease for 20% (12% 
if including non-cardiac causes). Other forms of cardiomyopathy (dilated, hypertrophic, 
congenital, restrictive and valvular) accounted for 13% of the cardiac causes and primary 
electrical diseases accounted for 5%. Unexplained cardiac arrests were observed in 3% of the 
patients which was in accordance with older studies reporting approximately 5% of patients 
with normal hearts after thorough examinations46. 
In summary, ischemic heart disease, acute or chronic, is still considered as the major cause of 
cardiac arrest47.  
The first recorded rhythm is considered an important clue when determining the etiology and 
reveals substantial information about prognosis. 
2.3.1 VF and pulseless VT in relation to etiology 
The proportion of EMS-treated patients with VF/pVT as the presenting rhythm ranges 
between 22-25%19,48,49. The proportion of patients with shockable rhythm has declined over 
the years for no clear reasons50. Among suggested possible reasons are improved cardiac 
prevention care and more frequent use of implantable cardioverter defibrillators (ICDs).  
If the presenting rhythm is shockable, the primary etiology is more often of ischemic heart 
disease origin51, either acute with coronary culprit lesions, or chronic with formation of 
ischemic cardiac scars. However, patients with ischemic etiology can also present with 
asystole and pulseless electrical activity (PEA). 
The pathophysiology of VF during myocardial-cell ischemia is complex but affects the 
resting membrane potential and K+ ion concentrations, leading to alterations in conduction, 
refractoriness and automaticity in myocardial cells52. 
Other causes of VF/pVT include ion-channel disorders, such as long QT-syndrome, Brugada 
syndrome and catecholaminergic polymorphic ventricular tachycardia (CPVT)45. 
Cardiomyopathies without ischemic etiology, such as dilated cardiomyopathy, hypertrophic 
cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy (ARVC) may also 
cause VF/pVT 53. 
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Figure 2. Mechanisms of cardiac arrest of cardiac cause. Huikuri et al.54. Reproduced with 
permission from NEJM 
2.3.2 Pulseless electrical activity (PEA) in relation to etiology 
The general definition of PEA is the absence of signs of circulation in the presence of 
electrical activity. However, the definition of PEA is not totally clear. One suggestion, from 
Myerburg et al., is that “PEA is a syndrome characterized by the absence of a palpable pulse 
in an unconscious patient with organized electric activity other than ventricular 
tachyarrhythmia on ECG”55. Another form of PEA is so called pseudo-PEA which can be 
described as a state without palpable pulse but with cardiac activity and ventricular 
contractions which can be detected by ultrasound56. 
A North American registry reported the proportion of cases of PEA to be 20%49. In Sweden, 
the proportion of OHCA patients presenting with PEA has increased, and in 2016 it 
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accounted for 22%57. PEA has been reported to be associated with older age, female gender 
and a history of pulmonary disease58.  
In experimental animal models asphyxia has been the model for the induction of PEA, which 
occurs in 3-11 minutes59. PEA may be caused by reversible conditions and if identified 
correct treatment could lead to ROSC. The causes of PEA are broadly considered as the 4Hs 
(Hypoxia, Hypovolemia, Hyper/Hypokalemia, Hypothermia) and 4Ts (Thrombosis, 
Tamponade, Toxins and Tension pneumothorax), described by Kloeck et al60 and assumed to 
be potentially reversible causes. Some of these are very rare causes of cardiac arrest, and 
according to a Swiss report the Hs&Ts represents only 55% of PEA cases61. Other causes are 
intracranial hemorrhage and non-ischemic cardiac causes. In the Swiss study, hypoxia and 
cardiac diseases were the primary etiologies of PEA.  
2.3.3 Asystole in relation to etiology 
Asystole is defined as the termination of electrical and mechanical activity of the heart. A 
large proportion of OHCA patients are found to have asystole at the scene of the arrest. If the 
first recorded rhythm is asystole the prognosis is poor, with a survival rate of 1-2%62-64.  
In many cases asystole could be viewed as a surrogate marker of prolonged resuscitation 
efforts in cardiac arrests of all origins and all presenting rhythms, and it is unclear how often 
asystole is the primary rhythm. Eventually all patients will end up with asystole if not 
detected and treated. 
 
Shockable rhythm conversion from initial asystole is associated with an increased rate of pre-
hospital ROSC and survival65,66. In a large review of patients with initial non-shockable 
rhythms 4.6 percent of patients had conversion to a shockable rhythm during CPR65. 
2.4 TOOLS TO DETERMINE THE ETIOLOGY OF OHCA 
2.4.1 Medical history and symptoms 
Comatose patients with ROSC after cardiac arrest cannot provide a medical history. 
Sometimes family members or the EMS can describe symptoms preceding the cardiac arrest. 
In one study a survey concerning warning symptoms prior to cardiac arrest was carried out. 
Among the deceased and survivors, 51% presented with at least one symptom within four 
weeks prior to their cardiac arrest. The most common symptom was chest pain, present in 
46% of patients, followed by dyspnea,18%, and palpitations or syncope present in 5%67. In a 
Japanese study it was reported that the most frequent symptom preceding cardiac arrest was 
dyspnea (27.6%), followed by chest pain (20.7%) and syncope (12.7%)68. Warning 
symptoms may activate the EMS faster, unless being ignored by the patient or family 
members, and this activation has been reported to be associated with improved survival67,69. 
Comorbidities existing prior to cardiac arrest might be of importance when assessing the 
cause of the arrest and, for prognosis. According to a large Swedish observational study70, the 
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most common comorbidities prior to arrest were congestive heart failure (29%), a history of 
myocardial infarction (24%), diabetes (23%) and chronic pulmonary disease (19%). 
Increasing comorbidity is associated with a decreased likelihood of survival irrespective of 
initial rhythm70-72.   
2.4.2 ECG 
In OHCA patients with ROSC and a secured airway 12-lead ECG should immediately be 
carried out, most preferably in the ambulance73. If the ECG after ROSC indicates ST-
elevation, the suspicion of a recent coronary event is high. In many observational studies it 
has been reported that ST-elevation has a high predictive value in diagnosing the presence of 
acute coronary lesions, ranging from 85% to 96%74,75. In contrast, Stær-Jensen et al. found 
that 37% of patients with ST-elevations showed normal coronary angiography76. For 
comparison, ECG in patients without cardiac arrest but with a high suspicion of acute 
myocardial infarction, ST-elevation has a predictive value ranging between 79-86% for an 
acute coronary lesion77,78. Large STEMI (ST-segment elevation myocardial infarction) 
registers have revealed that patients with OHCA represent approximately 10% of the total 
STEMI population admitted to hospital79. OHCA patients presenting with ST-elevation have 
a higher proportion of VF as primary rhythm compared with patients without ST-elevation80. 
Approximately 70-80% of OHCA patients present without ST-elevation on the ECG2,81,82. 
Most OHCA studies on ECG patterns merge these cases of non-ST-elevation into one 
comparison group76,83.  Observational studies report shifting proportions of significant 
coronary disease in patients without ST-elevation, ranging from 46-71%4,82,84.  
  
According to ESC (European Society of Cardiology) guidelines for the management of 
STEMI, “left bundle branch block (LBBB) with clinical suspicion of ongoing myocardial 
ischemia should be managed in a similar way to STEMI patients”7. In the setting of cardiac 
arrest, LBBB has a poor predictive value as regards an acute coronary event. Staer-Jensen et 
al. reported that reduced coronary flow was present in only 24% of patients presenting with 
LBBB76. In a study describing angiographic findings in relation to ECG, LBBB had the same 
proportion (40%) of normal coronary findings as normal ECG84. Both LBBB and right 
bundle branch block (RBBB) are frequent on the first ECG after cardiac arrest but seems to 
be transient85,86. In a Danish study it was observed that >90% of the LBBB´s and RBBB´s 
had resolved after four hours86. 
ST-depression and T-wave inversion are ECG signs suggestive of ischemia. A report from 
Norway presented the fact that in patients with ST-depression or T-wave inversion 24% had 
reduced coronary flow compared with 18% in patients with normal ECG76.  
To summarize, in observational studies it has been concluded that ECG after ROSC in 
OHCA patients is not a reliable method to identify acute coronary culprit lesions6,74,76,87.  
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Other ECG abnormalities 
Compared with ECG changes suggestive of coronary ischemia, ion-channel conditions such 
as long QT-time and Brugada syndrome can be found but are rarely seen after resuscitated 
cardiac arrest45. 
2.4.3 Coronary angiography 
The utilization of coronary angiography after OHCA has increased during the last 20 years88. 
The increased trend to perform coronary angiography after ROSC started with the landmark 
study by Spaulding et al. published in 1997, reporting high rates of significant coronary 
disease even among patients without ST-elevation87.  
European Society of Cardiology (ESC) guidelines for STEMI state that in patients with ST-
elevation following cardiac arrest, primary PCI is the strategy of choice. Furthermore, “in 
patients without ST-elevation, but with a high suspicion of ongoing myocardial ischemia, 
urgent coronary angiography, and PCI if indicated, should be considered”7.  
The latest European Resuscitation Council (ERC) guidelines, published in 2015, (post-
resuscitation-care section), state that “coronary angiography, and PCI if required, should be 
performed in patients with ROSC and ST-elevation on the ECG”8. In patients without ST-
elevation on the ECG, the ERC declare that it is “reasonable to discuss and consider emergent 
coronary angiography after ROSC in patients with the highest risk of a coronary cause for 
their cardiac arrest”8.  
The availability of coronary angiography varies between countries, regions and cities89. The 
decision to transfer a patient with recently ROSC to a hospital with 24/7 coronary 
angiography facilities may imply risks of new cardiac arrest and delays to target temperature 
management. However, transport distance has not been associated with lower survival rates90-
92 and it has been argued that all OHCA patients should be transported to cardiac-arrest 
centers with 24/7 coronary angiography facilities93,94. These arguments come from 
observational studies, with risks of bias, and currently there is a trial randomizing OHCA 
patients without ST-elevation for transportation to hospitals with 24/7 angiography facilities 
compared with standard care at the nearest hospital95.  
Coronary angiography is also associated with potential risks. Patients are exposed to contrast 
medium, which may impair renal function96,97, vascular risk from an invasive procedure and 
bleeding risk from antithrombotic medication98. 
2.4.4 Cardiac biomarkers 
Cardiac troponins and high-sensitivity troponin assays are of great value for early diagnosis 
of acute myocardial infarction in patients without cardiac arrest99. Elevated circulating 
troponin levels are specific for cardiomyocyte injury but not for myocardial infarction100. In 
resuscitated OHCA patients troponin levels are almost always elevated as a result of 
myocardial damage and the levels of troponins are related to the duration of 
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resuscitation101,102, and to prognosis103. Geri et al.104 conducted a study with the aim of 
determining whether or not assay of high-sensitivity cardiac troponin T was useful in 
diagnosis of recent coronary-artery occlusion as the cause of OHCA. Troponin T was 
assessed at ICU admission. They found that the optimum cut-off value of high-sensitivity 
troponin T was 575 ng/L with a sensitivity of 65.4% and specificity of 65.5% for recent 
coronary occlusion. However, the authors concluded that one blood sample of high sensitivity 
troponin T at the time of admission to an ICU was not enough as a diagnostic tool to select 
patients for coronary angiography after OHCA.  
N-terminal pro-B-type natriuretic peptide (NT-proBNP) is released by myocardial cells in 
response to atrial and ventricular stretch. NT-proBNP is most commonly used to diagnose 
and assess heart failure. Elevated NT-proBNP levels have been reported to be associated with 
an increased risk of ventricular arrhythmias105. Most comatose OHCA patients have elevated 
NT-proBNP levels, and increased NT-proBNP levels are associated with increased 
mortality106,107. 
2.4.5 Ultrasound 
The European Resuscitation Council guidelines states that “ultrasound may be of use in 
assisting with diagnosis and treatment of potentially reversible causes of cardiac arrest”73. 
Ultrasound represents a non-invasive and accessible tool to examine a cardiac-arrest patient. 
The challenge is to use it wisely during CPR. 
Ultrasound has been reported to be associated with prolonged interruptions of chest 
compressions108-110. The feasibility of using ultrasound during cardiac arrest depends on the 
image quality which has to be good enough for interpretation, and in one study it was 
reported that the image quality was not useful for interpretation in 40% of patients111. 
In patients with PEA there is a possibility to use ultrasound to determine the cause of the 
arrest112. Cardiac tamponade illustrates an example where ultrasound is the best tool to 
provide the correct diagnosis, with a high sensitivity and specificity113. Ultrasound has also 
been suggested as a tool in relation to termination of resuscitation efforts in non-shockable- 
rhythm patients without cardiac activity114,115.     
The use of ultrasound after ROSC in attempts to determine the etiology of arrest has not been 
studied in detail, but it has the potential to facilitate further decision-making as regards 
whether or not to perform immediate coronary angiography. 
2.4.6 Computed Tomography (CT)-thorax and head 
A respiratory or neurological cause of cardiac arrest should be considered in patients without 
ST-elevation on the first ECG. Examples of respiratory causes of cardiac arrest include 
severe pneumonia and acute on chronic respiratory failure116.  
Acute pulmonary embolism is an uncommon cause of cardiac arrest and has been reported to 
be responsible for 2.8-4.8% of cases117. Neurological causes of cardiac arrest are more or less 
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equal to major cerebrovascular bleeding, and in particular subarachnoid hemorrhage118, and 
they have been reported as the cause of cardiac arrest in 2.0-2.4% of patients116,118,119. 
Aortic dissection/rupture is a rare cause of cardiac arrest, with a reported incidence of 0.1-
2.3%116,120, and can be identified by CT-thorax. 
A report from the European association for percutaneous cardiovascular interventions 
(EAPCI) recommend a diagnostic work-up with CT-thorax and head in patients without ST-
elevation121. 
 
Figure 3. Proposed treatment algorithm from EAPCI. Noc et al.121. Reproduced with permission from 
EuroIntervention. 
 
A French study describing OHCA of neurological causes noted that 23% of patients had ST-
elevation on the admission ECG118. This ECG phenomenon may be caused by excessive 
catecholamine release with overload of the sympathetic nervous system122 and may inherit 
risk when decide on further clinical management in OHCA ST-elevation patients. 
2.5 CORONARY ANGIOGRAPHIC FINDINGS AND PCI  
ST-elevation after ROSC 
In patients with ST-elevation on the ECG after ROSC, observational studies indicate that the 
left anterior descending coronary artery (LAD) is the culprit vessel in the largest proportion 
of cases, 49-56%, the right coronary artery (RCA) in 18-33%, the left circumflex artery 
(LCX) in 11-22% and the left main coronary artery in 2-3.1%75,123,124. In patients presenting 
with ST-elevation after OHCA the rates of PCI have been reported to be between 71-
89%3,37,123. 
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European Resuscitation Council guidelines state that PCI should be performed in adult 
patients with ROSC and ST-elevation on the ECG8. There are no randomized studies 
supporting this recommendation, mostly because cardiac-arrest patients have been excluded 
from large randomized trials demonstrating the benefits of primary PCI in STEMI patients125. 
However, many observational studies report an association with improved survival if early 
revascularization is performed after ROSC in ST-elevation patients126,127. 
No ST-elevation after ROSC 
Patients without ST-elevation are a heterogeneous group of cardiac-arrest patients, and 
coronary angiographic findings and the rates of PCI are reported in different ways depending 
on the population studied. Most published studies report high proportions of significant 
coronary disease, ranging from 52-65%4,128-130. 
In observational studies, the finding of an occluded coronary artery, which should be of most 
interest, has been reported to occur in 22.9-27.0% of cases3,131,132. The only randomized study 
published, the COACT trial, included VF patients without cardiogenic shock, acute 
thrombotic occlusions were reported in 3.4% of the patients randomized to immediate 
coronary angiography130.  
In published observational studies, a culprit lesion deemed for PCI has been found in 21-41% 
of patients2,82,133,134, indicating that PCI was performed in some patients without coronary 
occlusion. In the COACT trial, PCI was performed in 33% of the patients randomized to 
immediate coronary angiography130.  
The distribution between coronary vessels identified as culprit-lesion locations and 
subsequently responsible for cardiac arrest has differed between studies. The left main 
coronary artery was identified as culprit in 7-13%, The LAD in 30-50%, the RCA in 23-29% 
and the LCX in 14-28% of cases3,80,131. 
In the COACT trial the proportion of cases of chronic total occlusion (CTO) was 37.7%130. 
The reporting of CTO has been rare in observational studies but in one study it was reported 
that 8% of the patients had CTO at the time of coronary angiography after OHCA3. 
Timing of coronary angiography in OHCA without ST-elevation 
It is of importance to determine if immediate coronary angiography is necessary because the 
procedure is associated with logistical and organizational challenges. Furthermore, immediate 
coronary angiography may delay the time to ICU monitoring and treatment. 
During the last 10 years many observational studies concerning OHCA patients without ST-
elevation, have been carried out in an attempt to answer the question of whether or not early 
coronary angiography improves survival compared with late or no coronary angiography. 
The limitations in the registers regarding the exact time point of coronary angiography result 
in expressions such as “Immediate coronary angiography”, “Emergent coronary 
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angiography” and “Early coronary angiography”, meaning everything from two hours to 24 
hours after cardiac arrest80,82,135. 
Hollenbeck et al.132 compared early versus late coronary angiography in patients with 
shockable rhythm and found that early coronary angiography was associated with a reduction 
in death rate. A Danish study showed that the use of emergent coronary angiography in 
patients without ST-elevation was not associated with reduced mortality80. In a post-hoc 
analysis of the TTM (Targeted Temperature Management) trial it was concluded that early 
coronary angiography was not associated with improved survival133. 
In the COACT trial 552 patients with initial shockable rhythm were randomized to a strategy 
of immediate coronary angiography compared with a strategy of delayed angiography after 
neurologic recovery. It was concluded that there was no difference between the groups in the 
primary endpoint of survival at 90 days (OR 0.89; 95% CI 0.62-1.27; p=0.51)130. The time 
from arrest to coronary angiography was 2.3 hours in the immediate-coronary-angiography 
group.  
 
Antithrombotic treatment 
 
Dual antiplatelet therapy is a fundamental treatment in patients undergoing PCI, carried out to 
prevent a new coronary event including stent thrombosis. In comatose OHCA patients 
intravenous administration should be considered before insertion of a nasogastric tube. There 
is a risk of decreased efficacy of orally administered antiplatelet therapy because of reduced 
absorption caused by gastroparesis and systemic inflammation after resuscitation, which may 
impair drug efficacy. 
 
In one large observational study it was reported that the incidence of stent thrombosis in 
OHCA patients undergoing PCI was 4.7%136. In comparison, myocardial-infarction patients 
without cardiac arrest and receiving a stent have a reported incidence of stent thrombosis of 
0.5-1.0%137,138. 
Survival in relation to ECG findings 
Several studies have shown that patients without ST-elevation have higher mortality rates 
compared with patients presenting with ST-elevation after ROSC3,4,80. However, a Dutch 
study showed no difference in survival when comparing ST-elevation and no ST-elevation 
after OHCA135. 
Treatment options for non-coronary causes  
Highly dependent on the presumed cause of cardiac arrest, treatment options are thrombolysis 
for pulmonary embolism117, pericardial drainage for cardiac tamponade139, correction of 
electrolyte abnormalities139 and use of antidotes in cases of suspected drug overdose140. 
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2.6 POST-CARDIAC-ARREST CARE IN THE INTENSIVE CARE UNIT 
Comatose survivors of cardiac arrest are subjects for monitoring, hemodynamic optimization, 
targeted temperature management and prognostication in the intensive care unit. Depending 
on the severity of whole-body ischemia, a great deal of patients develops post-cardiac arrest 
syndrome141, which consists of: 
- Post-cardiac arrest brain injury 
- Post-resuscitation myocardial dysfunction 
- Systemic ischemia/reperfusion response  
- Persistent precipitating pathology 
Targeted temperature management (TTM) is recommended for neuroprotection8. In the TTM 
trial, 939 patients were randomly assigned to 33 °C or 36 °C for 24 hours with prevention of 
fever for 72 h in both groups. At 180-days follow-up there was no difference in mortality or 
neurologic function between the groups142. This result raises the question of whether 
hypothermia rather than prevention of fever improves outcome, which is the rationale for the 
TTM2 trial143. 
Post-resuscitation myocardial dysfunction (PRMD) is characterized by myocardial stunning 
and reduced myocardial contraction and is affected by the acute or chronic underlying cause 
of the arrest144. The degree of PRMD tends to increase with longer duration of resuscitation. 
Hemodynamic instability after cardiac arrest may result from PRMD and/or from systemic 
vasodilation and often requires inotropic support and a vasopressor agent such as 
noradrenaline145. 
One randomized trial was carried out to investigate if mean arterial pressure (MAP) >85 
mmHg, by optimizing cerebral perfusion, compared with MAP >65 mmHg could improve 
neurological outcome in cases of resuscitated OHCA. The trial failed to show any difference 
in neurological outcome at 180 days146. 
Elevated lactate levels at admission have been associated with higher mortality in OHCA 
patients147,148, while faster lactate clearance has been shown to be protective149,150. 
One third of patients die from circulatory causes, mostly during the first two to three days in 
the ICU151. Two-thirds of patients dying after OHCA in the ICU die as a result of 
neurological injury induced by the no flow and low-flow circulation state during initial 
resuscitation 151,152. Neurological prognostication with a multimodal approach after 72 hours 
is recommended before deciding on withdrawal of life-sustaining treatment (WLST)153. 
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2.7 FURHTER EVALUATION OF ETIOLOGY 
Transthoracic echocardiography is essential after cardiac arrest for detection of abnormalities 
that suggest or confirm important causes of cardiac arrest. 
Cardiac magnetic resonance imaging (CMR) should be performed in selected patients to 
detect cardiomyopathies such as ARVC (arrhythmogenic right ventricular cardiomyopathy), 
myocarditis, cardiac sarcoidosis and cardiac amyloidosis and should be performed before a 
decision on ICD implantation. 
In patients resuscitated from shockable rhythm and with absence of reversible causes of 
cardiac arrest an ICD should be in place prior to discharge154. 
However, if there is clear evidence of myocardial infarction as the cause of arrest the patient 
could be evaluated at a later time for ICD implantation154.  
In cases of unexplained OHCA death (particularly in the young), obtaining a post-mortem 
blood sample, is recommended in the European Heart Rhythm Association guidelines155 in 
order to perform genetic testing that may provide valuable information for the family. 
 
2.8 NEUROLOGICAL FOLLOW-UP 
Severe neurological impairment is rare among OHCA survivors and most patients are 
categorized as cerebral performance category (CPC) 1 and 2, considered as good neurological 
outcome142. However, mild to moderate cognitive impairment is common among survivors. 
The consequences of cognitive deficits may lead to impairment in quality of life, depression 
and symptoms of fatigue156. A neuro-rehabilitation program focused on specific cognitive and 
psychological needs of patients could be beneficial156.   
 
2.9 GENDER ASPECTS 
Patients suffering from OHCA are predominantly men at a proportion of 64-72%157,158. 
Women tend to be older, to more often present with a non-shockable rhythm and have a 
lower chance of receiving bystander CPR157.  
In a French report, men were more likely to undergo early coronary angiography (70% vs 
49%). However, men had a higher prevalence of ST-elevation on the ECG (21% vs 13%). 
The report indicated no gender difference as regards survival159.  
A Swedish study, including only VF patients, was carried out to compare men and women. 
There was no gender difference as regards coronary angiography, but men had a higher 
prevalence of coronary artery disease (78 vs 54%) and more men had PCI following coronary 
angiography (59% vs. 42%). The study revealed no difference in survival160. 
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3 AIMS 
The overall aim of this work was to evaluate coronary angiography and other diagnostic 
approaches in out-of-hospital cardiac arrest patients and to investigate if early coronary 
angiography and potential subsequent PCI could improve outcome. 
The specific aims of the studies were: 
Study I: 
To evaluate the association between early coronary angiography (within 24 hours of arrest) 
and survival in OHCA patients without ST-elevation on the ECG. 
Study II: 
To investigate feasibility and safety aspects of randomizing unconscious OHCA patients 
without ST-elevation to immediate coronary angiography compared with standard-of-care in 
patients admitted primarily to the intensive care unit. 
Study III: 
To investigate how focused cardiac ultrasound shortly after ROSC is associated with the use 
of further diagnostic measures and if the detection of pulmonary embolism, cardiac 
tamponade and acute myocardial infarction could be improved. 
Study IV: 
To study if immediate coronary angiography with potential PCI influenced markers of post-
resuscitation myocardial dysfunction such as left-ventricular ejection fraction, biomarkers 
and lactate clearance in comparison with patients that were primarily admitted to the 
intensive care unit without immediate coronary angiography. 
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4 METHODS 
Table 2. Overview of study design, study population and data sources. 
 Study I Study II Study III Study IV 
Study design Observational 
retrospective 
study 
Randomized 
controlled trial 
Descriptive 
study 
Randomized 
controlled trial, 
Secondary 
analysis 
Numbers n=799 n=118 n=237 n=118 
Data source SRCR, 
SWEDEHEART, 
NPR, Medical 
records 
Study-CRF, 
SCAAR 
Local register, 
medical records 
Study-CRF, 
SCAAR 
Inclusion 
criteria 
Witnessed 
OHCA, VF, 
ECG without ST-
elevation 
Witnessed 
OHCA, ROSC 
Cardiac arrest 
admitted to the 
Medical ICU, 
ECG without 
ST-elevation 
Witnessed 
OHCA, ROSC 
Years 2008–2013 2015–2017 2012–2017 2015–2017  
Statistical 
method 
Descriptive 
statistics, logistic 
regression, Cox 
proportional 
regression 
Descriptive 
statistics 
Descriptive 
statistics 
Descriptive 
statistics 
Outcome 30-day survival, 
one and three-
year survival 
Feasibility, 
logistics and 
safety aspects 
FOCUS 
influence on 
management 
LVEF, 
Troponin 
levels, lactate 
clearance and 
NTproBNP 
levels 
SRCR, Swedish register for cardiopulmonary resuscitation; SCAAR, Swedish Coronary 
Angiography and Angioplasty Register; NPR, National patient register 
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4.1 STUDY I; OBSERVATIONAL COHORT STUDY 
Study design, population and data sources 
In this observational study, data from three different national registers were used. The first 
selection was from the Swedish register for cardiopulmonary resuscitation (SRCR) between 
2008 and 2013. Patients with bystander-witnessed OHCA, first recorded rhythm of VF or 
VT, admitted alive to hospital and patients aged 18-79 years were included. Excluded were 
patients with asystole or PEA as first recorded rhythm, conscious patients with a Glasgow 
Coma Scale score of >8 and patients aged 80 or more.  
The SRCR is a quality register for OHCA funded by the Swedish association of Local 
Authorities and Regions. Reports are entered in the register by all EMS organizations in 
Sweden if the EMS or bystanders have attempted resuscitation. Since 2010 all EMS 
organizations in all 21 regions in Sweden have reported to the register. The reports contain 
variables in accordance with the Utstein template10 for reporting cardiac arrest and 
cardiopulmonary resuscitation outcomes. The pre-hospital variables entered in the register are 
age, gender, whether the OHCA was witnessed or not, the first recorded rhythm, location of 
the arrest, bystander CPR, administration of drugs, defibrillation, time intervals and 
information on ROSC when admitted to hospital. A validation report in 2013161 showed that 
25% of all OHCAs were not reported prospectively by the EMS, but they were found after 
cross-checking of EMS records and entered retrospectively into the register.  
The SRCR dataset was merged with data from the SWEDEHEART register, including the 
RIKS-HIA register, which was used for ECG information and comorbidities. The SCAAR 
(Swedish Coronary Angiography and Angioplasty Register) register was used for coronary 
angiography and PCI variables. SCAAR contains information from all 29 centers performing 
coronary angiography and PCI in Sweden. SCAAR coverage during the study period was 
almost 100%. Coronary angiographic and PCI data in SCAAR are prospectively collected, 
audited and monitored according to defined standards162. 
Not all OHCA patients were registered in RIKS-HIA and SCAAR and therefore missing 
ECGs were collected from patients’ medical records.  
Additional data on comorbidities prior to cardiac arrest, and mortality, was collected from the 
National Patient Register, which is run by the Swedish National Board of Health and Welfare 
organization. Coverage regarding mortality is almost 100% because each Swedish citizen has 
a unique personal identification number163. All hospital admissions in Sweden are reported to 
the registry, together with international classification of disease codes (ICD-10 codes). 
National coverage regarding comorbidities in the National Patient Register is almost 100% 
and a validation has shown that 85-95% of all diagnoses are valid164.  
The study cohort was classified into two groups for comparison. “Early CAG”, defined as 
coronary angiography performed within 24 hours of the cardiac arrest, and “No Early CAG”, 
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defined as coronary angiography performed after 24 hours or not at all. The study endpoints 
were 30-day survival, and one- and three-year survival.  
Statistical methods 
Categorical variables were presented as numbers and percentages and continuous variables as 
medians with interquartile ranges (IQRs). Differences between categorical data were assessed 
by using the Chi-Square test and differences between continuous data was assessed by using 
the Mann-Whitney U test. Logistic regression analysis was performed to determine the 
association between early CAG and 30-day survival. Backward stepwise regression was used 
to limit the number of variables used in multivariate analysis. To calculate long-term survival 
a Cox proportional regression model was used.  
 
4.2 STUDY II AND IV; RANDOMIZED STUDY 
Study design, population, treatment protocol and data sources 
The DIrect or Subacute Coronary angiography in Out-of-hospital cardiac arrest study 
(DISCO) is an open-label, prospective, randomized, national multicenter clinical study 
(ClinicalTrials.gov ID: NCT02309151). The DISCO study was designed to compare a 
treatment strategy with immediate coronary angiography (with possible PCI), defined as 
angiography within 120 minutes of first medical contact, versus treatment based on current 
clinical practice after OHCA, with patients being admitted to an ICU and coronary 
angiography performed at a later stage.  
Patients eligible for the study were OHCA patients over aged 18 years or more with 
witnessed cardiac arrest, ROSC at the latest in the emergency room and coronary 
angiography possible within 120 minutes of first medical contact. Excluded were patients 
with ST-elevation on the first ECG, obvious non-cardiac cause of cardiac arrest, terminally ill 
patients with a life expectancy of less than one year, patients not unconscious (defined as 
Glasgow coma scale >8) and patients with known pregnancy. Studies II and IV present 
results from the initial pilot phase of the DISCO trial.  
In Study II the outcome measures were logistics, feasibility and safety aspects. 
In Study IV the outcome measures were left-ventricle ejection fraction at 24 hours, peak 
troponin T levels, levels of NT-proBNP at 72 hours and lactate clearance at six and 24 hours. 
The randomization procedure was performed through an online randomization module.  
Patients randomized to immediate coronary angiography were treated by following a 
revascularization protocol stating that “PCI should be performed on the presumed culprit 
lesion and that additional significant stenoses detected should be treated in addition to the 
culprit lesion, i.e., PCI should be carried out on all significant stenoses that are accessible to 
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PCI during the acute coronary angiography”. Significant stenoses referred to stenoses of 
>50% as estimated by the PCI operator. 
Patients randomized to standard-of-care were treated according to post-resuscitation 
guidelines in the ICU with potential coronary angiography performed not before three days. 
If circulatory instability, ventricular arrhythmias or ECG changes with ST-elevation occurred 
the attending physician could consider a coronary angiography before the stipulated three 
days. 
All study data were collected in a case-report form (CRF). All data were then entered into a 
web-based data system at the Uppsala Clinical Research Center. Data on coronary 
angiography was collected from the SCAAR register. Each study site was monitored by 
independent research nurses according to Good Clinical Practice standards. 
In the pilot phase of the study, OHCA patients with ST-elevation were also included as an 
observational group. This group was not randomized and was followed only for observation 
and for comparison regarding differences in timeframes, logistics and biomarkers. 
Statistical methods 
To assess feasibility and safety aspects, a sample size of 80 randomized patients was chosen. 
The sample size was predefined in the study protocol. The analyses included all enrolled 
patients, randomized patients without ST-elevation and patients with ST-elevation. Owing to 
the limited number of patients presented no comparative statistical measures were performed 
in Study II. Continuous variables were presented as medians and IQR. Categorical variables 
were presented as total numbers of patients and proportions (%) in each group. In Study IV 
differences between the groups were analyzed using the Chi-square test for categorical 
variables and the Mann-Whitney U test for continuous variables.  
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4.3 STUDY III; RETROSPECTIVE, DESCRIPTIVE STUDY 
Study design, population and data sources 
A retrospective, descriptive, single-center study conducted at Södersjukhuset between 2012 
and 2017. The study was designed to describe how focused cardiac ultrasound (FOCUS) was 
used and associated with further diagnostic measures and if the detection of pulmonary 
embolism, cardiac tamponade and acute myocardial infarction (AMI) could be improved in 
the setting of post-ROSC cardiac arrest. 
Patients included in the study were all adults resuscitated from cardiac arrest and admitted to 
the Medical ICU at Södersjukhuset. All patients identified as having successful resuscitation 
following OHCA or in-hospital cardiac arrest (IHCA) without any restrictions in care were 
included. Patients with ST-elevation on the ECG, patients admitted from other hospitals, 
patients without focused cardiac ultrasound examination and patients with obvious non-
cardiac or respiratory causes of the cardiac arrest were excluded. The FOCUS examination 
was performed by the attending echocardiography-certified cardiologist. 
To identify the patients, the local hospital register for cardiac arrest was used. Study variables 
were reviewed retrospectively from electronic medical records and organized in an 
anonymized local database. Interpretation of whether or not the FOCUS findings influenced 
further management was adjudicated from the patient’s records by two cardiologists at 
different time points. Information on management was documented, together with the 
patient’s final diagnosis established by clinical judgment or autopsy. 
Statistical methods  
Categorical variables were presented as total numbers and proportions and continuous 
variables were presented as medians and IQRs. Owing to the descriptive design of the study 
no comparative statistical tests were performed. 
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4.4 ETHICAL CONSIDERATIONS 
The studies were approved by the regional ethics review board in Stockholm (Study I, 
approval number 2014/1139-31/2, Studies II and IV, approval number 2014/1170-31/1, Study 
III approval number 2016/1332-31). 
Studies I and III were retrospective studies, and the possible harm to the participating patients 
was considered to be low.  
Conducting research on unconscious cardiac-arrest patients requires caution. For natural 
reasons, unconscious OHCA patients cannot provide informed consent to participate in a 
randomized clinical trial.  
Because of the design of the DISCO study, with enrolment as soon as possible after sustained 
ROSC, and the nature of the participants, comatose survivors after OHCA, informed consent 
could not be obtained before randomization. 
When conducting a randomized trial there must be a balance of risk and benefit for the 
participants. When the DISCO study was designed there was (and still is) conflicting 
evidence concerning whether or not immediate coronary angiography could improve survival 
rates in OHCA patients without ST-elevation. 
Potential harm to patients randomized to immediate coronary angiography could be harm 
attributed to the intervention and potential harm in patients randomized to standard care in the 
ICU could be lack of revascularization of an occluded coronary artery, with potential 
consequences. The DISCO study protocol states that in “patients randomized to standard care 
coronary angiography could be performed before three days if the patient develop circulatory 
instability, ST-elevation on the ECG or serious ventricular arrhythmias”165. 
In the DISCO study, relatives were asked for consent after randomization, most often in the 
ICU and in a few cases several weeks afterward. In one case the next of kin declined to give 
consent. All patients who survived were informed about the trial and asked for written 
informed consent. None of the survivors declined to give consent in the study. 
During the timeline of a randomized clinical trial, new evidence could be presented which 
could ethically question continuation of the trial. The COACT trial130 was presented in 2019 
and the results tend to strengthen the continuation of the DISCO trial. 
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5 RESULTS 
5.1 STUDY I; SURVIVAL IN OHCA-VF PATIENTS WITHOUT ST-ELEVATION 
Study population 
During the study period 26,173 OHCA patients were treated by the EMS and among those, 
5178 were witnessed and admitted alive to hospital. Patients with asystole/PEA, awake 
patients, patients aged less than 18, or 80 years or more and patients with ST-elevation or 
presumed new LBBB on admission were excluded. A total of 799 patients were included in 
the final analysis. Early CAG within 24 hours was performed in 275 patients. The “no early 
CAG” group included 524 patients. 
 
Figure 4. Study I flow chart. 
 
Main results 
Unadjusted 30-day survival in the early-CAG group was 65%, compared with 52% in the no-
early-CAG group. The adjusted OR for 30-day survival was 1.42 for early CAG (95% CI 
1.00-2.02, p=0.048). The adjusted HR for one-year survival was 1.35 (95% CI 1.04-1.77). 
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Figure 5. Survival using Cox proportional regression analysis, HR, adjusted hazard ratio at 
three years. 
 
                                                                                                        Reprinted with permission from Elsevier. 
Table 3. Angiographic findings 
 
                                                                                                                  Reprinted with permission from Elsevier. 
 
The proportion of significant stenoses was 70% in the Early-CAG group and 64% in the 
Late-CAG group. PCI was performed in 51% in the Early-CAG group and 34% in the Late-
CAG group. 
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5.2 STUDY II; DISCO PILOT STUDY 
Study population 
In this study 79 patients were randomized from January 1st, 2015 to October 15th, 2017. 
There were 39 patients randomized to immediate coronary angiography and 40 patients to 
standard-of-care. In the observational ST-elevation group, 39 patients were included. 
 
Figure 6. 
 
 
Reprinted with permission from Elsevier. 
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Feasibility 
In the immediate-angiography group, the median time from EMS arrival to coronary 
angiography was 135 minutes (Q1-Q3: 106-178).  
When reevaluating the inclusion and exclusion criteria, we found that 10 patients did not fully 
meet the study criteria (mainly cases of non-witnessed cardiac arrest and awake patients). 
However, they were included in the pilot phase of the study on a to intention-to-treat basis. 
Due to the lack of 24/7 coronary angiography services in two of the participating study 
centers, transportation between primary and tertiary hospitals occurred in seven out of 38 
cases (18.4%). No serious events occurred during the transportation from the primary hospital 
to the tertiary center.  
Cross-over 
 In the standard-of-care group six patients underwent coronary angiography earlier than three 
days after the cardiac arrest. The reasons for earlier coronary angiography were new onset of 
ST-elevation, high troponin levels and echocardiography indicating ischemia. 
 
Table 4. Time periods 
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Coronary angiography and PCI findings 
In the immediate-angiography group a culprit lesion was found in 14/38 patients (36.8%), 
PCI was performed in 15/38 patients (39.5%) and assessed as successful in 14/15 (93%) 
patients. 
 
Table 5. Coronary angiography and PCI 
 
Categorical variables are presented as numbers (%). Abbreviations: LAD: Left artery descending, LCX: Left circumflex 
artery, RCA: Right coronary artery, PCI: Percutaneous coronary intervention, VT: Ventricular tachycardia, VF: Ventricular 
fibrillation ˟Complete revascularization of those identified as significant stenosis outside identified culprit vessel 
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5.3 STUDY III; FOCUSED CARDIAC ULTRASOUND AFTER ROSC 
Study population 
In this descriptive study, 237 patients with FOCUS examination were evaluated. The majority 
were included after OHCA (n=182, 77%) and a minority after IHCA (n=55, 23%). 
 
Figure 7. Flow chart Study III 
 
Reprinted with permission from Elsevier. 
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Main results 
The influence of FOCUS pathology findings in terms of leading to further diagnostic 
measures was detected in 21.9% of the patients. The decision to perform CT-thorax because 
of right ventricular dilatation and/or right ventricular pressure overload occurred in 8.9% of 
the patients. Left-ventricular FOCUS findings, with regional wall-motion abnormalities 
influenced the decision to perform emergency coronary angiography in 7.2% of the patients. 
 
Table 6. Influence of FOCUS findings 
Reprinted with permission from Elsevier. 
 
Table 7. Etiology of the cardiac arrest 
Reprinted with permission from Elsevier. 
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5.4 STUDY IV; POST-RESUSCITATION MYOCARDIAL DYSFUNCTION 
Study population 
In this secondary analysis of the DISCO pilot study 39 patients were randomized to 
immediate coronary angiography and 40 patients to standard-of-care. In the observational ST-
elevation group, 39 patients were included. 
Main results 
There was no significant difference in LVEF observed at 24 hours after the cardiac arrest, 
with a mean LVEF of 47% (Q1-Q3; 30-55%) in the immediate-angiography group compared 
with 46% (Q1-Q3; 35-55) in the standard-of-care group. Peak troponin-T levels during the 
first 24 hours were 362 ng/L (Q1-Q3; 174-2020) in the immediate-angiography group 
compared with 377 ng/L (Q1-Q3;205-1078) in the standard-of-care group. Levels of NT-
proBNP at 72 hours were 931 ng/L (Q1-Q3; 396-2845) in the immediate angiography group 
compared with 1913 ng/L (Q1-Q3; 489-3140) in the standard-of-care group. 
 
Table 8. Outcome measures, Study IV 
 No ST elevation  
Outcome measures Immediate CAG 
n=38 
Standard care 
n=40 
P-value 
Ejection fraction (%), median (Q1-Q3) at 
24h 
47 (30-55) [n=28] 46 (35-55) [n=30] 0.74 
Troponin-T (ng/L) peak value, median (Q1-
Q3) 
362 (174-2020) 
[n=31] 
377 (205-1078) 
[n=31] 
0.77 
NT-proBNP (ng/L) at ICU admission, 
median (Q1-Q3) 
749 (356-2945) 
[n=28] 
1431 (160-2390) 
[n=26] 
0.75 
NT-proBNP (ng/L) at 72 hours, median (Q1-
Q3) 
931 (396-2845) 
[n=20] 
1913 (489-3140) 
[n=17] 
0.64 
Lactate clearance at 6 hours1, (%) 70.7 (56.0-79.5) 
[n=30] 
75.2 (68.1-85.0) 
[n=34] 
0.08 
Lactate clearance at 24h1, (%) 81.5 (75.0-88.0) 
[n=26] 
79.5 (66.0-85.4) 
[n=32] 
0.31 
1Lactate clearance at x h was calculated as 100x (Lactate at admission-Lactate at x h)/Lactate at admission 
 
 
 
 
 
 
 
 
 
 
 
 
 32 
When comparing those patients who underwent PCI (n=15) vs. no PCI (n=23), the median 
LVEF at 24 hours was 50% in the revascularized patients compared with LVEF 45% in those 
with immediate angiography where PCI was not performed. 
 
Table 9. Impact of PCI in patients undergoing immediate angiography divided into four 
subgroups 
bLactate clearance at 6h was calculated as 100 x (initial lactate – 6-hour lactate) / initial lactate. 
 
 
 
                                                         No ST-elevation                                                  ST-elevation 
Outcome measures 
Immediate 
coronary 
angiography - PCI 
n = 15 
 
Immediate 
coronary 
angiography - 
no PCI 
n = 23 
 
P-value 
Observation 
- PCI 
n = 26 
 
Observation - 
no PCI 
n = 13 
 
P-value 
Ejection Fraction (%) 
at 24 h, median, 
(Q1-Q3) 
50 (30-55) [n=11] 45 (40-55) 
[n=17]  
0.80 45 (33-55) 
[n=20] 
40 (34-50) 
[n=10] 
0.72 
Troponin T (ng/L) at 
hospital admission, 
median (Q1-Q3) 
102 (29–789) 
[n=14] 
49 (23–127) 
[n=17]  
0.14 173 (53–903) 
[n=22] 
93 (31–264) 
[n=12] 
0.14 
Troponin T (ng/L) 
peak value, median 
(Q1-Q3) 
1395 (408–2500) 
[n=14]  
227 (145–379) 
[n=17] 
0.04 3100 (903–
8650) [n=22]  
854 (463–
1820) [n=12] 
0.03 
       
NT-proBNP (ng/L) at 
ICU admission, 
median (Q1-Q3) 
870 (250–3160) 
[n=11]  
1274 (373–2945) 
[n=17]  
0.67 380 (111–
1490) [n=20]  
1355 (67–
3110) [n=10]  
0.83 
NT-proBNP (ng/L) at 
72h, median (Q1-
Q3) 
1260 (773–3200) 
[n=7] 
939 (400–4030) 
[n=13] 
1.0 1260 (934–
1953) [n=18] 
975 (422–
1821) [n=8]  
0.33 
       
Lactate clearance at 
6hb 
median, (Q1-Q3) 
64.3 (37.8–78.5) 
[n=10]  
71.1 (60.6–76.3) 
[n=20]  
0.33 71.3 (54.2–
79.6) [n=24] 
83.9 (76.1–
87.9) [n=11]  
0.01 
Lactate clearance at 
24hb 
Median, (Q1-Q3) 
80.5 (70.4–88.8) 
[n=11]  
83.6 (79.3–86.7) 
[n=15]  
0.50 75.7 (66.7–
86.8) [n=24] 
85.1 (79.8–
88.7) [n=11] 
0.07 
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6 DISCUSSION 
Why does myocardial ischemia cause cardiac arrest? 
 
Historically, acute myocardial ischemia caused by an occluded coronary artery has been 
considered the dominant mechanism of VF and cardiac arrest. It still plays a significant role 
although its dominance has been challenged by other recognized mechanisms. 
Cardiac arrest associated with transient ischemia most often presents without ST-elevation on 
the ECG and could be related to a proximal high-grade stable coronary stenosis, and transient 
ischemia is initiated by the inability to meet flow requirements under a specific condition 
such as increased demand during physical activity, or supraventricular tachycardia. This 
initiates regional variations in myocardial-cell membrane electrophysiology and causes 
ventricular arrhythmias52.  
Most patients with stable, unstable or acute coronary artery disease do not suffer from cardiac 
arrest, which implies that other factors must be present. It has been suggested that a strong 
genetic component exists in the risk of cardiac arrest166,167, and promising genetic studies 
have been presented to quantify the risk of cardiac arrest168. However, the underlying genetic 
variation remains unknown. It has been suggested that the manifestation of fatal arrhythmias 
is the result of an interaction between substrate, trigger, and modulating factors169. 
 
Figure 8. Mechanisms of cardiac arrest of cardiac cause. Myerburg51 et al Reproduced with permission from 
Circulation. 
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A Danish study group compared STEMI patients with and without VF before PCI and they 
recognized a family history of sudden death, absence of angina, high alcohol intake, younger 
age and history of atrial fibrillation to be independent risk factors of VF124. 
 
What are the potential benefits of performing immediate coronary angiography in OHCA 
patients without ST-elevation? 
Considering the high burden of ischemic heart disease in OHCA patients, coronary 
angiography is a reasonable diagnostic procedure after ROSC, but there are inherent logistical 
and organizational challenges as a result of variable availability of coronary angiography 
facilities between hospitals and regions. If a culprit lesion is detected, subsequent PCI could 
be performed and might salvage myocardial muscle, improve ventricular function and 
prevent the recurrence of ventricular arrhythmias170. However, the recurrence of ventricular 
arrhythmias is frequent during the first 24 h after ICU admission even in revascularized 
patients probably because of ischemia-reperfusion injuries170.  
In survivors, revascularization may prevent the development of ischemic heart failure. The 
high rates of obstructive coronary disease observed in patients presenting without ST-
elevation do not per se explain the cardiac arrest and other causes must be considered, 
especially in the absence of an occluded coronary artery. 
Normal coronary angiography findings provide essential diagnostic information, since the 
absence of an acute coronary event is an important finding, which would can speed up the 
search for alternative causes of the cardiac arrest. A normal coronary angiography finding 
will also lead to termination of antiplatelet therapy, which might decrease the risk of bleeding 
during post-cardiac arrest care. 
 
Figure 9. Benefits and risks of immediate coronary angiography.  
 
Revascularization with PCI 
Improved cardiac contractility 
Avoidance of arrhythmias 
Provides diagnostic information 
Bleedings and renal failure 
Delayed ICU-care and TTM 
May require transportation to other hospital 
Stent thrombosis 
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What are the potential risks of performing immediate coronary angiography in OHCA 
patients without ST-elevation? 
Immediate coronary angiography after ROSC is not without risk. It requires exposure to 
contrast agents with an increased risk of renal failure171, a vascular risk at the access site172, 
where femoral access is more common in this acute setting, and bleeding risks from 
antiplatelet drugs. In OHCA patients undergoing PCI there is also an increased risk of stent 
thrombosis136 compared with patients without cardiac arrest. 
 
Transferring unstable patients between hospitals in order to perform an immediate coronary 
angiography may be difficult, with inherent risks. Trying to cut time to the start of coronary 
angiography in OHCA patients could lead to insufficient clinical examination before 
angiography, with the risk of not detecting other potential treatable causes of the arrest, and 
the risk of delaying other treatment options. Other possible challenges are delays in initiating 
post-resuscitation measures such as target temperature management. In addition, respiratory 
or circulatory instability might be more difficult to handle outside the ICU. 
Furthermore, immediate coronary angiography is a resource-intensive and costly 
intervention. 
 
However, in Study II the rate of bleedings and signs of renal failure were low. In the larger 
COACT trial130 the rate of major bleeding complications was low and actually higher in the 
delayed-angiography group (4.9% vs 2.6%), probably because of lower utilization of 
antithrombotic medication due to the fact that normal coronary angiography without a need 
for PCI could exclude antithrombotic agents.  
In summary, immediate coronary angiography may be considered safe in OHCA patients 
arriving at hospitals with angiography facilities and who do not require transfer to another 
hospital.   
 
When to perform coronary angiography in OHCA without ST-elevation? 
Observational studies have shown a high rate of occurrence of coronary artery disease in 
patients without ST-elevation on the ECG which makes immediate coronary angiography an 
attractive strategy.  
According to the results of the COACT trial130 it is safe to wait for neurologic recovery 
before performing coronary angiography which could be interpreted as keeping OHCA 
patients without ST-elevation at the nearest hospital without coronary angiography facilities 
is safe. This argument goes against the idea of centralizing all OHCA patients to cardiac 
arrest-centers.  
The results of the COACT trial are consistent with the results of several randomized trials, 
concerning NSTEMI patients without cardiac arrest, which have shown no survival benefit of 
immediate coronary angiography compared with delayed coronary angiography173,174.  
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How early is early? 
Early is not the same as immediate when it comes to coronary angiography, and in many 
patients it might be favorable to wait and collect further clinical information such as Troponin 
changes, a more detailed medical history from next of kin, and exclusion of other causes after 
DT-thorax and head examinations. 
In Study II and in the COACT trial there was a small but not negligible proportion of cross-
overs in the control group. These patients showed signs of myocardial infarction such as 
elevated Troponins, ECG changes suggesting ongoing ischemia and echocardiographic signs 
of regional wall motion abnormalities. 
 
A proposal might be to wait for up to six hours to identify those patients that might benefit 
from coronary angiography and possible PCI. The advantages of this concept would include 
avoiding unnecessary activation of the coronary angiography lab at night, avoiding 
transportation of a circulatory unstable patient to another hospital and increasing the 
likelihood of PCI.    
 
For whom? How to select patients for immediate coronary angiography? 
It is important to identify which patients will probably benefit from treatment with PCI. It is 
as important to identify those who will not benefit from immediate coronary angiography. It 
is thus essential to assess the likelihood of PCI and the likelihood of poor neurologic outcome 
when selecting patients for an invasive strategy. The effects of hypoxic brain injury reduce 
the potential value of PCI because neurologic injury remains the leading cause of death in an 
ICU. Accordingly, neurologic prognosis should be evaluated first before transfer for coronary 
angiography, especially in OHCA patients without ST-elevation.  
A reliable prognostication tool could be of great value since there is no specific clinical sign 
to predict neurologic outcome in the first few hours after ROSC. The Cardiac Arrest Hospital 
Prognosis (CAPH) score is intended to stratify neurological outcome after OHCA175 and 
consists of seven variables associated with poor prognosis: Non-shockable rhythm, age, time 
from collapse to basic life support (BLS), time from BLS to ROSC, location of the arrest, 
epinephrine dose, and arterial pH. This score was tested in an observational study and showed 
that only patients with low-risk scores could benefit from early coronary angiography 
regardless of the presence of ST-elevation176. 
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How to predict an acute coronary culprit lesion immediately after ROSC? 
The only established predictor of a coronary culprit lesion/occlusion is ST-elevation on the 
ECG after ROSC. However, approximately 70% of OHCA patients present without ST-
elevation, which makes it more challenging to predict a culprit lesion. Suggested predictors in 
these patients might be: 
• Preceding symptoms such as chest pain. 
• Medical history of coronary artery disease or diabetes. 
• Initial shockable rhythm. 
• ECG with ST-depression. 
• Regional left-ventricle-wall-motion abnormalities in FOCUS examination. 
• Initial high-sensitivity troponin T levels of more than 150 ng/L. 
This prediction model is a suggestion and comes with limitations, since in many cases 
information on these predictors is not available, and it has not been validated. 
 
Does coronary angiography improve survival after OHCA? 
In several observational studies, including Study I, higher rates of survival in patients 
undergoing early coronary angiography have been reported3,87,132. However, is it possible that 
a diagnostic tool may improve survival after cardiac arrest? One can argue that the main 
question should be if revascularization, i.e. PCI, has the potential to improve outcomes in 
resuscitated OHCA patients without ST-elevation on the ECG.  
The results of some observational studies suggest that PCI drives the benefit of coronary 
angiography81,177. In one observational study, focusing on patients without ST-elevation, it 
was reported that successful PCI was associated with improved outcome compared with no 
PCI2. In another study it was concluded that early coronary angiography, but not PCI, was 
associated with improved outcome132, indicating a risk of selection bias.  
The largest published randomized trial, the COACT trial130, including patients with VF and 
ECG without ST-elevation, revealed no difference in survival between immediate coronary 
angiography compared with coronary angiography after ICU-discharge. At 90 days, 64.5% in 
the immediate-angiography group and 67.2% in the delayed-angiography group were alive 
(OR, 0.89, 95% CI, 0.62-1.27; p = 0.51). The PCI rate was 33% in the immediate group and 
24.2% in the delayed group, which indicates that the trial was underpowered to answer the 
question of whether or not immediate coronary angiography with revascularization could 
improve survival in patients without ST-elevation after OHCA. 
In summary, coronary angiography per se does not improve survival, but revascularization of 
an acute occluded coronary artery should decrease the risk of dying as a result of 
cardiovascular conditions, although it is unlikely that revascularization could improve 
neurological outcome.  
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Why do the results differ between observational and randomized OHCA studies? 
In observational studies the decision on which subjects receive coronary angiography is not 
entirely random and thus there is an inherent potential source of bias. Most observational 
studies demonstrate lower mortality rates in OHCA patients undergoing coronary 
angiography, even when PCI is not performed, which serves as a good example of 
confounding. In observational studies the early coronary angiography group may differ 
systematically from those that are not undergoing early coronary angiography. This is 
denoted as confounding by indication178. One other potential cause of bias in observational 
studies on coronary angiography after OHCA is the risk of dying during the first few hours 
after cardiac arrest and thereby being excluded from the intervention. This type of bias is 
called waiting-time bias or time-dependent bias, which may exist in Study I.  
There are various statistical methods to adjust for confounding factors, but it is impossible to 
correct for all variables clinicians consider when selecting patients for immediate coronary 
angiography or no immediate coronary angiography, this is so-called residual confounding.  
Randomized controlled trials represent the gold standard for evaluating the efficacy of 
interventions, avoiding bias by randomly allocating participants to the treatment or control 
groups179. In observational studies the treatment is chosen by the clinician rather than 
randomly assigned. 
One of the major challenges in randomizing OHCA patients without ST-elevation is that 
clinicians may believe it is wrong to randomize patients if they are convinced that the 
treatment being studied is effective. When large numbers of patients are excluded from 
randomized trials, generalizing the results becomes more difficult. Another difficulty in 
performing an RCT lies in recruiting a sufficient number of patients, which has been a 
challenge in Studies II and Study IV. 
 
What is the diagnostic performance of an ECG in cardiac arrest versus no cardiac arrest? 
In cardiac-arrest research publications, the frequent occurrence of an occluded coronary 
artery in patients without ST-elevation, is often reported. However, does that differ from the 
situation among patients without cardiac arrest?  
In patients presenting without cardiac arrest and no ST-elevation on the ECG, i.e. NSTEMI-
patients, a recent published meta-analysis presented the fact that 25.5% had an occluded 
culprit artery180, which is comparable to the figure reported in cardiac-arrest patients without 
ST-elevation reporting an occluded coronary vessel in 22.9-27.0% of the patients3,131.  
 
The challenge in cardiac arrest compared with NSTEMI is that the patients most often are 
unconscious and other diagnostic measures such as Troponins and chest pain are difficult to 
assess properly. 
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In OHCA patients ECG findings of LBBB and RBBB are more frequent than in patients with 
myocardial infarction without cardiac arrest85. In Study I the proportion of cases of RBBB 
was 12.5%, consistent with figures in other studies85. Bundle-branch block is often transient 
in cardiac-arrest patients which could be explained by global hypoxia during the arrest, 
differing from the situation in patients without cardiac arrest, where a bundle branch block 
should increase the suspicion of a coronary culprit lesion.   
 
Why was the DISCO pilot study performed and what were the experiences of it? 
When designing the DISCO trial, it was, to our knowledge, the first clinical trial in which it 
was planned to randomize unconscious OHCA patients without ST-elevation and with recent 
ROSC to either immediate coronary angiography or standard care. The main reasons for 
conducting the DISCO pilot study were to assess the feasibility of the randomization 
procedure, the informed-consent procedure, implementation of the intervention, evaluate 
adherence to protocol, the cross-over rate and assess the enrollment rate. 
The pilot sample size was pragmatic and based on the necessities for examining feasibility. 
The pilot study result was never intended to be used for sample size calculations for the main 
DISCO study. 
Because of the adaptive design of the DISCO study, the angiographic findings in the control 
group were not presented and 30-day survival was not assessed. 
Experiences from the DISCO pilot study, Study II 
Immediate angiography was performed at a later time point than the 120 minutes from first 
medical contact stipulated in the protocol and it was changed to 120 minutes from 
randomization, after evaluation of the pilot-study results. 
During the timeline of the pilot study, the Culprit-Shock trial was published181, reporting a 
higher risk of immediate multi-vessel PCI in cardiogenic shock patients, and the complete 
revascularization strategy was changed to culprit-lesion-only PCI in the DISCO-study 
protocol. 
 
Unfortunately, many eligible patients were not randomized, which may introduce a risk of 
selection bias in the main DISCO trial. The low enrollment rate was interpreted as a 
consequence of the strong belief among many clinicians that immediate coronary 
angiography should be carried out in all OHCA patients. The neutral results from the 
COACT trial may make it easier for clinicians to randomize patients in the DISCO trial since 
it is now more difficult to argue for immediate angiography in OHCA patients without ST-
elevation. 
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When and how could FOCUS be used in cardiac arrest? 
Ultrasound is increasingly being incorporated into cardiopulmonary resuscitation and can be 
performed during CPR and after ROSC. It has been suggested to be used as a prognostic and 
diagnostic tool during CPR, especially in PEA patients. The use of FOCUS as a diagnostic 
tool during CPR is very time-dependent, because high-quality CPR requires minimal 
interruptions in chest compression, and good FOCUS image quality is difficult to obtain.  
The use of ultrasound after ROSC is not as time dependent as when it is performed during 
CPR and the opportunity to obtain good image quality for interpretation is better. 
Right-ventricular echocardiographic abnormalities are common after ROSC. Acute right- 
ventricle dilatation occurs shortly after the cardiac arrest as blood is translocated from the 
systemic circulation to the right side of the heart. The results of Study III suggest that 
dilation of the right ventricle in combination with-right ventricular pressure overload should 
be present in order to suspect pulmonary embolism as the cause of the arrest. 
Regional wall-motion abnormalities (RWMAs) in ultrasound suggestive of acute myocardial 
infarction may be difficult to identify. In Study III we found that RWMAs observed in 
FOCUS examination were not enough to predict a culprit lesion detected in coronary 
angiography.   
The scientific evidence for using ultrasound as a diagnostic tool in cardiac arrest situations is 
scarce. However, its advantage is that it is non-invasive and carries no risk to the patient. 
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7 FUTURE PERSPECTIVES 
There is still no consensus of opinion in the clinical and scientific community about the value 
of immediate coronary angiography in OHCA patients without ST-elevation.  
The recently published COACT trial was underpowered and there was a lack of 
generalizability to non-shockable patients. Furthermore, definite conclusions should not be 
drawn from a single trial. However, there are several ongoing randomized clinical trials with 
very similar inclusion and exclusion criteria. The DISCO trial with a sample size of 1006 
patients, the German TOMAHAWK trial182 with a sample size of 558 patients and the French 
EMERGE trial (ClinicalTrials.gov number, NCT02876458) are recruiting patients. The 
results of these trials will be important as regards providing scientific evidence and guiding 
clinical practice. Some of these trials will also involve assessment of left-ventricular ejection 
fraction at six months. 
  
A related research question is if OHCA patients without ST-elevation should be transferred to 
a regional cardiac-arrest center. Those running the randomized ARREST trial95 are currently 
enrolling patients to answer this question. 
Since ultrasound is frequently used in conjunction with cardiac arrest, there is a need for 
prospective trials carried out to evaluate the usefulness of focused cardiac ultrasound after 
ROSC in cardiac-arrest patients. 
A validated scoring model to predict a coronary cause of the cardiac arrest is also of interest 
for guiding clinical practice. Such a scoring model would take into account the combination 
of symptoms preceding the arrest, age, gender, comorbidities, primary rhythm, ECG, cardiac 
ultrasound and high sensitivity Troponin in order to increase the accuracy of detecting a 
culprit lesion in immediate coronary angiography after OHCA. 
  
The increased implementation, knowledge and experience of coronary-CT in clinical practice 
for non-cardiac-arrest patients, makes this technique appealing to use in OHCA patients 
without ST-elevation. Either to rule in, or out, an acute coronary event responsible for the 
cardiac arrest. As described earlier in this work it has been suggested to perform a CT-thorax 
and head in OHCA patients without ST-elevation121. If adding coronary-CT to these 
examinations valuable information would be presented as to whether or not an invasive 
coronary angiography should be performed. 
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8 CONCLUSIONS 
Study I 
In this population of bystander-witnessed cases of out-of-hospital cardiac arrest with 
shockable rhythm and ECGs without ST-elevation, early coronary angiography may be 
associated with improved short- and long-term survival. 
Study II 
In this population of bystander witnessed out-of-hospital cardiac arrest patients without ST-
elevation, a strategy to perform immediate coronary angiography was feasible, although the 
time-window of 120 min from EMS arrival at the scene of the arrest to the start of coronary 
angiography was not achieved. No significant safety issues were reported. 
Study III 
The retrospective data in this cardiac-arrest population supports the fact that advanced life 
support conformed post-resuscitation care could include FOCUS as an adjunctive diagnostic 
measure shortly after ROSC. 
Study IV 
In this secondary analysis of OHCA patients without ST-elevation on the ECG randomized to 
immediate coronary angiography or standard care, we found no differences in post-
resuscitation myocardial dysfunction parameters between the groups. 
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9 POPULÄRVETENSKAPLIG SAMMANFATTNING PÅ 
SVENSKA  
I Sverige inträffar varje år ca 6000 hjärtstopp utanför sjukhus där ambulans tillkallas och 
påbörjar behandling. Andelen som överlever till 30 dagar är 10%, dvs 600 personer överlever 
varje år. 
Ett hjärtstopp innebär att hjärtat plötsligt slutar att pumpa blod. Efter några sekunder faller 
den drabbade ned medvetslös eftersom hjärnan drabbas av syrebrist. Hjärtstoppet kan utlösas 
av ett så kallat kammarflimmer som gör att hjärtats kammare flimrar istället för att pumpa ut 
blod i kroppen. Den enda behandling som kan hjälpa utanför sjukhus är hjärt-lungräddning 
och en tidig strömstöt från en hjärtstartare för att återställa hjärtats normala pumpfunktion. 
 
En av de vanligaste orsakerna till hjärtstopp är hjärtinfarkt. Hjärtinfarkt orsakas av stopp eller 
delvis stopp i hjärtats kranskärl som försörjer hjärtat med blod och syre. Den syrebrist som 
uppstår i hjärtmuskeln kan leda till kammarflimmer och hjärtat stannar. 
 
De flesta som får hjärtstopp utanför sjukhus avlider innan ambulansen kommer fram till 
sjukhus. En fjärdedel kommer dock in till sjukhus med pumpande hjärta. De flesta är dock 
medvetslösa och kan inte återberätta vad som inträffat.  
 
En av de första åtgärder man gör på sjukhus är att kontrollera ett EKG. Om EKG visar tydliga 
tecken på hjärtinfarkt (ST-höjning) är den omedelbara åtgärden kranskärlsröntgen för att 
kontrollera hjärtats kranskärl. Om det är stopp i ett kranskärl kan man öppna kranskärlet. 
När hjärtat har börjat pumpa igen är det vanligt att man kontrollerar hjärtat med fokuserat 
ultraljud för att försöka utröna orsaken till hjärtstoppet och för att vägleda fortsatt utredning 
och behandling.  
Om EKG inte visar tydliga tecken på hjärtinfarkt är det inte självklart att kranskärlsröntgen är 
den omedelbara åtgärden. Det finns en tydlig kunskapslucka om man ska utföra 
kranskärlsröntgen på patienter med EKG utan tydliga tecken på hjärtinfarkt och om fokuserat 
ultraljud av hjärtat är användbart för fortsatt handläggning. 
Målsättningen med avhandlingsarbetet var att belysa några av dessa kunskapsluckor och 
besvara frågorna: 
 
1. Kan tidig kranskärlsröntgen jämfört med sen eller ingen kranskärlsröntgen förbättra 
överlevnaden hos patienter med hjärtstopp utanför sjukhus med EKG utan tydliga tecken på 
hjärtinfarkt? 
2. Är det praktiskt genomförbart att randomisera patienter med hjärtstopp utanför sjukhus 
utan tydliga tecken till hjärtinfarkt på EKG? 
3. Kan fokuserat ultraljud av hjärtat vara behjälpligt för att ta reda på orsaken till hjärtstoppet 
och kan ultraljud av hjärtat vägleda fortsatt utredning och behandling? 
4. Kan akut kranskärlsröntgen påverka hjärtfunktionen efter hjärtstopp på patienter utan säkra 
EKG-tecken till hjärtinfarkt? 
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Studie I var en observationsstudie där historiska data från svenska kvalitetsregister användes. 
Svenska hjärt-lungräddningsregistret användes och data kompletterades från svenska 
hjärtinfarkts registret och svenska registret för kranskärlsröntgen (SWEDEHEART). Mellan 
åren 2008–2013 registrerades 799 patienter med hjärtstopp utanför sjukhus med 
kammarflimmer som första rytm, medvetslösa vid ankomst till sjukhus, 18–85 år gamla samt 
avsaknad av ST-höjning på första EKG. Två grupper jämfördes avseende kort och 
långtidsöverlevnad: 1. Tidig kranskärlsröntgen 2. Sen eller ingen kranskärlsröntgen. 
Studie I visade att 65% av de som gjorde tidig kranskärlsröntgen överlevde till 30 dagar 
jämfört med 52% av de som gjorde sen eller ingen kranskärlsröntgen. 
Efter justering för störningsfaktorer blev slutsatsen att tidig kranskärlsröntgen är associerat 
med ökad 30-dagars överlevnad. 
  
Studie II var en randomiserad kontrollerad studie där bevittnade hjärtstopp utanför sjukhus 
utan ST-höjning på EKG lottades till omedelbar kranskärlsröntgen eller sedvanlig vård på 
intensivvårdsavdelning. 
Syftet med studie II var att utvärdera genomförbarhet, logistik och säkerhetsaspekter att 
randomisera dessa patienter i form av en pilotstudie eftersom en randomiserad studie aldrig 
genomförts på denna patientgrupp. De patienter som inkluderades var över 18 år, hade 
bevittnat hjärtstopp och kranskärlsröntgen bedömdes kunna genomföras inom 120 minuter 
från första medicinska kontakt samt medvetslösa patienter. De patienter som exkluderas var 
de med ST-höjning på EKG, de med uppenbar icke-kardiell orsak till hjärtstoppet (överdos, 
trauma eller hängning), patienter med terminal sjukdom med förväntad överlevnad mindre än 
ett år. Under pilotfasen följdes även de med ST-höjning på EKG som en observationsgrupp, 
men de randomiserades inte.  Mellan 2015 och 2017 randomiserades 79 patienter och 39 
patienter följdes i observationsgruppen. 
 
Studie II visade att mediantiden från första medicinska kontakt till kranskärlsröntgen var 135 
minuter. Transport mellan primärt mottagande sjukhus och sjukhus med möjlighet till 
kranskärlsröntgen inträffade i sju fall. Inga allvarliga händelser inträffade under transporten. 
Sex patienter som blev randomiserade till sedvanlig intensivvård genomförde 
kranskärlsröntgen tidigare än 3 dagar. 
Konklusionen var att det är möjligt att randomisera denna patientgrupp. Inga allvarliga 
säkerhetsfrågor rapporterades. Det noterades dock att tiden från första medicinska kontakt till 
kranskärlsröntgen översteg 120 minuter.  
Studie III var en beskrivande tillbakablickande studie med syfte att belysa hur fokuserat 
ultraljud på hjärtat används på hjärtstoppspatienter efter att hjärtat har börjat pumpa igen. Den 
hade även som syfte att beskriva hur ultraljud på hjärtat kunde vägleda till fortsatt utredning 
och behandling. Data inhämtandes från journaler på patienter vårdade på medicinska 
intensivvårdsavdelningen Södersjukhuset mellan åren 2012–2017. Ca 80% av patienterna 
blev inlagda pga hjärtstopp utanför sjukhus och 20% blev inlagda på intensivvårdsavdelning 
efter hjärtstopp på sjukhus. 
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Studie III visade att fokuserat hjärtultraljud påverkade handläggningen i 22% av fallen. 
Ultraljud som visade regional rörelseinskränkning i hjärtats vänsterkammare påverkade 
beslutet att genomföra akut kranskärlsröntgen hos 7% av patienterna. Ultraljud som visade 
förändringar på hjärtats högerkammare påverkade beslutet att genomföra skiktröntgen av 
lungorna hos 9% av patienterna.  
 
Studie IV var en sekundäranalys av Studie II med syfte att jämföra hjärtats 
vänsterkammarfunktion, nivåer av hjärtskademarkörer (Troponiner) samt metabolismen av 
mjölksyra mellan de två randomiserade grupperna. 
 
Studie IV visade att det inte var någon skillnad mellan grupperna avseende 
vänsterkammarfunktion, hjärtskademarkörer eller metabolism av mjölksyra. 
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